Additionally, male sex, TP53, BIRC3 and EGR2 aberrations were significant factors for U-CLL, while mutations in NOTCH1 and NFKBIE were significant markers in M-CLL. This evidence concerns the gene EGR2 and B-cell chronic lymphocytic leukemia.